New Jersey Harm Reduction Coalition (NJHRC) announced today that the organization is expanding its mail-based naloxone and harm reduction program. To manage the expansion, NJHRC is pleased to announce the hire of Sheilah Powell (she/her) as Manager of Mail-Based Services and Community Distribution.
Yesterday, the US Food and Drug Administration (FDA) approved the first ever over-the-counter form of naloxone. This approval applies only to the 4mg nasal spray manufactured by Emergent Biosolutions, which is significantly more expensive than other more affordable versions, including intramuscular naloxone. In response, New Jersey Harm Reduction Coalition (NJHRC) released the following statement.Jenna Mellor, … Read more
Earlier today in New Jersey’s State of the State address, Governor Murphy announced the launch of Naloxone365. This new program will enable every pharmacy in New Jersey to provide 4mg nasal spray naloxone anonymously and for free to any resident who requests it, at any time throughout the year. When the Murphy Administration started the … Read more
Today on International Overdose Awareness Day, Newark Mayor Ras Baraka, Department of Human Services Commissioner Sarah Adelman, and Department of Health Commissioner Judith Persichilli joined Vital Strategies and advocates from Newark Community Street Team and the New Jersey Harm Reduction Coalition to unveil the first installation of a traveling national Overdose Memorial. Located at Newark … Read more
By David Matthau, WKXW-FM
Frequently Asked Questions About Co-Prescribed Naloxone Why am I being prescribed naloxone with my pain medication? In May 2020, the New Jersey Office of the Attorney General issued an administrative order requiring anyone who prescribes you an opioid medication for pain management equal to or greater than 90 morphine milligram equivalents (MME) to also prescribe … Read more
